Nuclear Imaging Equipment Market To Reach USD 4,463.7 Million by 2030

As per a report by P&S Intelligence, the size of the nuclear imaging equipment market was USD 2,651.3 million in 2021, and it will grow at a rate of 6% in the years to come, for reaching USD 4,463.7 million by 2030.

For example, the SPECT/CT system allows specific localization and improved specificity of the data delivered by a CT scan, in the case of skeletal inspection. Numerous hospitals are progressively switching from standalone to hybrid equipment because of these advantages.

Some of the current progressions in imaging technology that are applicable to radionuclide therapy include:

A main benefit of PET/MRI over PET/CT is an improved soft tissue contrast, which is essential for treatment planning, dosimetry, and post-radionuclide therapy assessment. It is beneficial since it offers the concurrent co-registration of MR descriptions, which is significant for precise dosimetry.

Also, numerous nations, chiefly the U.S. and those in Europe, are making a eagerness assessment framework for effective and smart ways of putting to use radio drugs, so as to offer safe and effective treatments. Therefore, most hospitals are concentrating on the therapy for cancer patients, encouraged by its high efficiency and few side-effects. Nuclear imaging is by now making a main contribution in detecting the area of spread of the cancer in the body.

Doctors can rapidly compare scans to precisely track the ailment's course, with the usage of integration of data. Clinicians now wish easy access to comprehensive data on patient diagnostic history, for developing a treatment plan that would be fruitful along with being cost-effective.

It is because of the increasing aging population, the demand for nuclear imaging equipment will be om the rise in the future.

Read More

Cover Corona Outbreak Impact: Nuclear Imaging Equipment Market is expected to Boom in Coming Years

The global nuclear imaging equipment market is predicted to demonstrate rapid advancement in the coming years. Nuclear imaging procedures are painless and non-invasive medical tests that help healthcare practitioners diagnose the medical conditions of patients. Nuclear imaging involves the use of radioisotopes that are directly administered into the bloodstream, inhaled, or swallowed for providing images of how the organs and tissues function. Radioisotopes emit radiations that are used for diagnosing cancer and evaluating organ disorders.

Access Report Summary - Nuclear Imaging Equipment Market Segmentation Analysis

The rising incidence of cancer and the surging population of geriatric people are the major factors propelling the advancement of the nuclear imaging equipment market across the globe. As per the International Agency for Research on Cancer (IARC), which is a specialized cancer agency of the World Health Organization (WHO), nearly 12.7 million new patients were diagnosed with cancer all over the world in 2008 and this number will rise to 21.4 million by 2030. 

Furthermore, in 2012, 8.2 million people lost their lives around the world because of cancer. Out of these deaths, lung cancer was responsible for the deaths of 1.6 million people, while, live cancer claimed the lives of 745,000 people. Moreover, as many as 400,000 people lost their lives because of esophageal cancer in 2012. The rapidly surging pool of people undergoing cancer screening and cancer diagnostic tests is positively impacting the demand for nuclear imaging equipment across the world. 

Furthermore, the share of geriatric people in the global population will reach 21.1% by the end of 2050. When application is taken into consideration, the nuclear imaging equipment market is categorized into cardiology, oncology, and neurology. Amongst these, the oncology category recorded the highest growth in the market in the past, as per the observations of the market research company, P&S Intelligence. The market is also divided, depending on end user, into research institutes, hospitals, and diagnostic centers. 

Read More